Simon Dumesnil - Nov 15, 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Director
Signature
/s/ Simon Dumesnil
Stock symbol
KTTA
Transactions as of
Nov 15, 2022
Transactions value $
$53,100
Form type
4
Date filed
11/17/2022, 03:34 PM
Previous filing
Sep 14, 2021
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Award $10.7K +10K $1.07 10K Nov 15, 2022 Direct
transaction KTTA Common Stock Award $42.4K +40K +400% $1.06 50K Nov 17, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTTA Stock Option (to acquire Common Stock) Award $0 +100K $0.00 100K Aug 2, 2021 Common Stock 100K $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 100,000 stock options which have a ten-year term. The option is vested and exercisable with regard to 50,000 shares of Common Stock. The remaining 50% vest, subject to Mr. Dumesnil's remaining employed and in good standing, on August 2, 2023.